(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1663500

アピゲニンの世界市場：原料別・形状別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Apigenin Market, By Source, By Form, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.92円
アピゲニンの世界市場：原料別・形状別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年01月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

アピゲニンの市場規模は2024年に37億2,032万米ドルとなり、2025年から2032年にかけてCAGR 4.50%で拡大

アピゲニンの市場力学

医薬品および栄養補助食品業界における天然抗酸化物質および抗がん化合物に対する需要の増加

消費者の健康意識の高まりにより、合成化合物よりも植物由来の天然化合物を好む傾向が高まっています。アピゲニンはその強力な抗酸化特性で知られ、心血管疾患、神経変性疾患、老化関連問題などの慢性疾患の主要因である酸化ストレスと闘うのを助けます。さらに、アポトーシスを誘導し、腫瘍細胞の増殖を抑制するなどの抗がん作用により、がんの予防と治療研究において非常に注目されています。栄養補助食品では、アピゲニンは免疫サポート、抗炎症効果、一般的な健康をターゲットとした栄養補助食品にますます使用されるようになっており、予防ヘルスケアソリューションに対する需要の高まりを反映しています。インドAYUSH省の報告書によると、天然抗酸化物質を含む植物由来の健康製品の世界市場は、伝統薬やハーブ薬を促進する政府の支援イニシアティブにより、大きな成長を遂げています。このシフトは、合成成分よりも天然化合物を支持する広範な健康動向と一致しており、医薬品と栄養補助食品の未来を形成する上でアピゲニンの重要な役割を浮き彫りにしています。持続可能な調達と技術の進歩は、市場の可能性をさらに高めると思われます。

アピゲニン市場：主な考察

  • 当社のリサーチアナリストが共有した分析によると、世界市場は予測期間 (2025-2032年) に約4.50%のCAGRで毎年成長すると推定されています。
  • 原料別では、天然は2024年に最大の市場シェアを示すと予測されました。
  • 用途別では、食品・飲料が2024年の主要セグメントです。
  • 地域別では、北米が2024年に主要な収益源となりました。

アピゲニン市場：セグメンテーション分析

世界のアピゲニン市場は、原料、形状、用途、地域によって区分されます。

市場は原料に基づいて2つのカテゴリに分かれています：天然と合成です。天然が市場を独占しているのは、副作用が少なく健康効果が実証された、植物由来の環境に優しい製品に対する消費者の嗜好が高まっているためです。さらに、オーガニック成分に対する規制上のサポートが、アピゲニンのような天然由来の化合物の需要をさらに押し上げています。

市場は用途別に4つのカテゴリーに分けられます：医薬品、食品・飲料、化粧品・パーソナルケア、栄養補助食品です。アピゲニンは天然の抗酸化剤や保存料として広く使用され、製品の保存性や栄養価を高めているため、食品・飲料が市場を独占しています。健康を促進する生物活性化合物を豊富に含む機能性食品や食品・飲料に対する消費者の需要の高まりが、さらにその優位性を後押ししています。

アピゲニン市場：地域別分析

北米、特に米国では、医薬品、栄養補助食品、機能性食品における天然成分や植物由来成分に対する消費者の嗜好が高まっており、アピゲニンの主要市場の一つとなっています。この需要を支えているのは、抗酸化物質や抗がん化合物の健康効果に対する意識の高まりです。加えて、強固な規制の枠組みや研究の進歩も、この地域における市場の成長に寄与しています。欧州では、食品、食品・飲料、パーソナルケアにおけるオーガニック・天然製品の動向の高まりにより市場が拡大しています。欧州連合 (EU) の食品や化粧品に含まれる合成化学物質に対する厳しい規制が、アピゲニンのような植物由来成分の採用を増加させ、市場の成長をさらに後押ししています。アジア太平洋、特にインドや中国のような国々は、健康サプリメントや食品における伝統的なハーブ療法や天然製品へのシフトの高まりによって、アピゲニン市場の急速な成長を目の当たりにしています。ヘルスケアにおけるハーブや天然成分の使用を促進する政府のイニシアチブも、この地域における市場の拡大に寄与しています。

アピゲニン市場：競合情勢

アピゲニン市場は、天然抗酸化物質や健康促進化合物に対する需要の増加を活用することに焦点を当てた数多くの起業で構成される競合情勢によって特徴付けられます。主要企業は、市場での地位を強化するために、製品の革新、パートナーシップ、コラボレーションなどの様々な戦略を採用しています。企業はアピゲニンの生物学的利用能と有効性を高めるための研究開発に投資しており、医薬品、栄養補助食品、化粧品への応用を推進しています。加えて、植物由来やオーガニック原料へのシフトは、天然かつ持続可能なソースから高品質のアピゲニンを調達するためのサプライヤー間の競争激化につながっています。市場シェアという点では、医薬品と栄養補助食品のセクターは競争が激しく、企業は規制当局の承認を確保し、健康志向の消費者にアピールする製剤を開発しようと競い合っています。食品・飲料セクターもまた競争が激しく、抗酸化物質が豊富な製品に対する需要の高まりに対応するため、機能性食品や飲料にアピゲニンを配合するメーカーがあります。さらに、化粧品業界は、アンチエイジングと肌を落ち着かせる特性を持つアピゲニンをますます活用するようになっており、美容・パーソナルケア市場における競争を激化させています。アピゲニン市場の世界な性質は、天然健康ソリューションに対する消費者の需要が急速に伸びているアジア太平洋やラテンアメリカなどの新しい地域市場を開拓し、国際的な足跡を拡大することを奨励しています。

目次

第1章 アピゲニン市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 アピゲニンの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 アピゲニン市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 アピゲニン市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 アピゲニンの市場情勢

  • アピゲニンの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 アピゲニン市場：原料別

  • 概要
    • セグメント別シェア分析：原料別
    • 自然
    • 合成

第8章 アピゲニン市場：形状別

  • 概要
    • セグメント別シェア分析：形状別
    • 粉末
    • 液体

第9章 アピゲニン市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 医薬品
    • 食品・飲料
    • 化粧品・パーソナルケア
    • 栄養補助食品
    • その他

第10章 アピゲニン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ (LATAM)
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ (MEA)
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：アピゲニン業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Monteloeder SL
    • Sigma-Aldrich Corporation
    • Aksuvital GIda Sanayi ve Ticaret AS
    • Bo International Pvt. Ltd.
    • Indo Phytochem Pharmaceuticals Pvt. Ltd.
    • Shaanxi QingLan Bio-Technology Co., Ltd.
    • Xi'an Incedit Bio-Tech Co., Ltd.
    • Xi'an Sost Biotech Co., Ltd.
    • Shaanxi Pioneer Biotech Co., Ltd.
    • Xi'an Lyphar Biotech Co., Ltd.
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4688

REPORT HIGHLIGHT

Apigenin Market size was valued at US$ 3,720.32 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

Apigenin is a bioactive flavonoid widely found in fruits, vegetables, and herbs, particularly in parsley, celery, and chamomile. It is renowned for its antioxidant, anti-inflammatory, and anti-cancer properties. Structurally belonging to the flavone class, apigenin plays a crucial role in health and wellness industries due to its diverse therapeutic benefits and minimal side effects compared to synthetic drugs. The growing need for apigenin is driven by its significant health benefits. As a potent antioxidant, it neutralizes free radicals, reducing oxidative stress, a key factor in aging and chronic diseases. Its anti-inflammatory effects make it valuable for managing arthritis and cardiovascular disorders. Apigenin is also gaining attention in oncology, where it has demonstrated the ability to induce apoptosis and inhibit tumor growth in cancers such as breast, prostate, and colon. Furthermore, its neuroprotective properties support brain health by promoting neuron formation and reducing the risk of neurodegenerative diseases like Alzheimer's. In the cosmetics industry, apigenin is used for its skin-soothing and anti-aging properties, enhancing product formulations aimed at skin rejuvenation. Additionally, its incorporation into dietary supplements addresses consumer demand for natural health-enhancing ingredients, making it a critical compound in various sectors, from pharmaceuticals to nutraceuticals.

Apigenin Market- Market Dynamics

Increasing demand for natural antioxidants and anti-cancer compounds across pharmaceuticals and nutraceutical industries

Increasing health awareness among consumers has led to a rising preference for plant-based and naturally derived compounds over synthetic alternatives, given their reduced side effects and holistic health benefits. Apigenin, known for its potent antioxidant properties, helps combat oxidative stress, a key factor in chronic conditions such as cardiovascular disease, neurodegenerative disorders, and aging-related issues. Furthermore, its anti-cancer effects-such as inducing apoptosis and inhibiting tumor cell proliferation-make it highly sought after in cancer prevention and treatment research. In nutraceuticals, apigenin is increasingly used in dietary supplements targeting immune support, anti-inflammatory effects, and general wellness, reflecting the growing demand for preventive healthcare solutions. According to a report from the Indian Ministry of AYUSH, the global market for plant-based health products, including natural antioxidants, is experiencing substantial growth due to government-backed initiatives promoting traditional and herbal medicines. This shift aligns with broader health trends favoring natural compounds over synthetic ingredients, highlighting the critical role of apigenin in shaping the future of pharmaceuticals and nutraceuticals. Sustainable sourcing and technological advancements will further enhance its market potential.

Apigenin Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)
  • Based on Source segmentation, Natural was predicted to show maximum market share in the year 2024
  • Based on Application segmentation, Food & Beverages was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Apigenin Market- Segmentation Analysis:

The Global Apigenin Market is segmented on the basis of Source, Form, Application, and Region.

The market is divided into two categories based on Source: Natural and Synthetic. Natural dominates the market due to increasing consumer preference for plant-based, eco-friendly products with minimal side effects and proven health benefits. Additionally, regulatory support for organic ingredients further drives demand for naturally sourced compounds like apigenin.

The market is divided into four categories based on Application: Pharmaceuticals, Food & Beverages, Cosmetics & Personal Care, and Dietary Supplements. Food & Beverages dominates the market due to its widespread use as a natural antioxidant and preservative, enhancing product shelf life and nutritional value. Growing consumer demand for functional foods and beverages enriched with health-promoting bioactive compounds further drives its dominance.

Apigenin Market- Geographical Insights

In North America, particularly the United States, there is a growing consumer preference for natural and plant-based ingredients in pharmaceuticals, nutraceuticals, and functional foods, making it one of the leading markets for apigenin. This demand is supported by increasing awareness of the health benefits of antioxidants and anti-cancer compounds. Additionally, the robust regulatory framework and advancements in research contribute to the market's growth in this region. In Europe, the market is expanding due to the rising trend of organic and natural products in food, beverages, and personal care. The European Union's stringent regulations on synthetic chemicals in food and cosmetics have increased the adoption of plant-derived ingredients like apigenin, further fueling market growth. The Asia-Pacific region, especially countries like India and China, is witnessing rapid growth in the apigenin market, driven by a growing shift toward traditional herbal remedies and natural products in health supplements and food. Government initiatives promoting the use of herbal and natural ingredients in healthcare also contribute to the market's expansion in this region.

Apigenin Market- Competitive Landscape:

The Apigenin market is characterized by a competitive landscape with numerous players focused on capitalizing on the increasing demand for natural antioxidants and health-promoting compounds. Key market players adopt various strategies such as product innovation, partnerships, and collaborations to strengthen their market position. Companies are investing in research and development to enhance the bioavailability and effectiveness of apigenin, driving its application across pharmaceuticals, nutraceuticals, and cosmetics. Additionally, the shift towards plant-based and organic ingredients has led to heightened competition among suppliers to source high-quality apigenin from natural and sustainable sources. In terms of market share, the pharmaceutical and nutraceutical sectors are highly competitive, with businesses vying to secure regulatory approvals and develop formulations that appeal to health-conscious consumers. The food and beverages sector also sees competition, with manufacturers incorporating apigenin in functional foods and beverages to cater to the rising demand for antioxidant-rich products. Moreover, the cosmetics industry is increasingly leveraging apigenin for its anti-aging and skin-soothing properties, intensifying competition in the beauty and personal care market. The global nature of the market encourages players to expand their footprint internationally, exploring new regional markets such as Asia-Pacific and Latin America, where consumer demand for natural health solutions is rapidly growing.

Recent Developments:

  • In May 2024, Tally Health launched its Restore Sleep and Longevity Formula, a blend of ingredients targeting improved sleep and overall longevity. The formula combines several botanicals and nutraceuticals aimed at promoting relaxation and reducing age-related health issues.
  • In April 2024, 4Life launched Transfer Factor AgePro, a new product combining apigenin with other powerful compounds aimed at enhancing immune support and promoting longevity. This product builds on 4Life's commitment to scientifically backed formulations and proprietary ingredients, including exclusive plant extracts, designed to boost health and wellness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL APIGENIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Monteloeder S.L.
  • Sigma-Aldrich Corporation
  • Aksuvital GIda Sanayi ve Ticaret A.S.
  • Bo International Pvt. Ltd.
  • Indo Phytochem Pharmaceuticals Pvt. Ltd.
  • Shaanxi QingLan Bio-Technology Co., Ltd.
  • Xi'an Incedit Bio-Tech Co., Ltd.
  • Xi'an Sost Biotech Co., Ltd.
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Xi'an Lyphar Biotech Co., Ltd.
  • Others

GLOBAL APIGENIN MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Natural
  • Synthetic

GLOBAL APIGENIN MARKET, BY FORM - MARKET ANALYSIS, 2019 - 2032

  • Powder
  • Liquid

GLOBAL APIGENIN MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceuticals
  • Food & Beverages
  • Cosmetics & Personal Care
  • Dietary Supplements
  • Others

GLOBAL APIGENIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Apigenin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Apigenin Market Snippet by Source
    • 2.1.2. Apigenin Market Snippet by Form
    • 2.1.3. Apigenin Market Snippet by Application
    • 2.1.4. Apigenin Market Snippet by Country
    • 2.1.5. Apigenin Market Snippet by Region
  • 2.2. Competitive Insights

3. Apigenin Key Market Trends

  • 3.1. Apigenin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Apigenin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Apigenin Market Opportunities
  • 3.4. Apigenin Market Future Trends

4. Apigenin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Apigenin Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Apigenin Market Landscape

  • 6.1. Apigenin Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Apigenin Market - By Source

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 7.1.2. Natural
    • 7.1.3. Synthetic

8. Apigenin Market - By Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Form, 2024 & 2032 (%)
    • 8.1.2. Powder
    • 8.1.3. Liquid

9. Apigenin Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Pharmaceuticals
    • 9.1.3. Food & Beverages
    • 9.1.4. Cosmetics & Personal Care
    • 9.1.5. Dietary Supplements
    • 9.1.6. Others

10. Apigenin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Apigenin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Apigenin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Apigenin Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Apigenin Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Apigenin Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Apigenin Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Monteloeder S.L.
    • 11.2.2. Sigma-Aldrich Corporation
    • 11.2.3. Aksuvital GIda Sanayi ve Ticaret A.S.
    • 11.2.4. Bo International Pvt. Ltd.
    • 11.2.5. Indo Phytochem Pharmaceuticals Pvt. Ltd.
    • 11.2.6. Shaanxi QingLan Bio-Technology Co., Ltd.
    • 11.2.7. Xi'an Incedit Bio-Tech Co., Ltd.
    • 11.2.8. Xi'an Sost Biotech Co., Ltd.
    • 11.2.9. Shaanxi Pioneer Biotech Co., Ltd.
    • 11.2.10. Xi'an Lyphar Biotech Co., Ltd.
    • 11.2.11. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us